Funding for this research was provided by:
Institut National Du Cancer (2016-043)
Austrian Science Fund (P 29608)
European Commission (313010)
Received: 25 February 2020
Accepted: 9 July 2020
First Online: 3 September 2020
Ethics approval and consent to participate
: Each participating study obtained informed consent from the study participants and approval from its institutional review board. This study was approved by the IARC Ethics Committee on 11 February 2016 (Project No. 16-12).In genetic consortia, all participants provided written informed consent and studies were approved by their respective institutional review boards and those of participating registries as required.
: Not applicable
: The authors declare that they have no competing interests.